Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022, in JAMA Psychiatry
key takeaway: "Trends in the number of incident prescriptions dispensed nationally for Schedule II (C-II) stimulant and nonstimulant medications for attention-deficit/hyperactivity disorder (ADHD) significantly increased during the COVID-19 pandemic, exceeding prepandemic rates, notably in young adults and women. Incident prescription trends for antidepressants, benzodiazepines, and buprenorphine for opioid use disorder did not significantly change."